Covir logo
WebsiteBitforex Launchpad

Covir (CVR)

ICO
IEO

Covir is a platform that is designed to fund biosafety projects and licenses using blockchain technology. Biosafety licenses funded by Covir are for Octopus robots products.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Project industryHealth & Medicine
Product typeOrganization
FoundedSwitzerland
WhitepaperCovir White Paper Open

Technical details

The token contract was developed using SmartPy and the code is available onto our github (github.com/covir-io). You can also read the full specifications onto our github page (readme.md). The contract was beforehand extensively tested onto babylonnet and carthagenet.

What is Covir

Covir is a platform that is designed to fund biosafety projects and licenses using blockchain technology. Biosafety licenses funded by Covir are for Octopus robots products; Octopus robots design biosafety equipment that decontaminates large buildings such as shopping malls, airport terminals, and food processing plants. Without a doubt, Covir project is the best blockchain project to invest in because biosafety projects are currently underrepresented in the blockchain world, despite there being a lot of opportunities in the biosafety industry. The current ravaging COVID-19 pandemic has accelerated the need for biosafety equipment.

Details

Pre-sales: Mar 01, 2020 - Aug 01, 2020
Public sales: Aug 01, 2020 - Sep 01, 2020
IEO (Bitforex Launchpad): Jul 31, 2020 - Aug 25, 2020
Token supply: 400,000,000 CVR
Soft cap: 500,000 USD
Hard cap: 24,000,000 USD
Raised: 160,000 USD

Legal

Blockchain Platform: Tezos
Registration year: 2017
Office address: Rue Ancienne 88, 1215 Carouge GENEVE

Token info

Ticker: CVR
Type: Utility-token
Token standard: FA 1.2
Token price in USD: 1 CVR = 0,20 USD
Accepted currencies: BTC, ETH, TRX, XTZ, USD
Token distribution:
75% – Octopus Robots
10% – Operational costs
10% – Team & Advisors
5% – Reserve / Security Fund

Covir Roadmap

1
1987_Company

Foundation of the company. It was named MCAI until April 2017. Initially, the company was specializing in developing and manufacturing metrology products for industrial applications.

2
2004_Mr Olivier Somville

The company was taken over by Mr. Olivier Somville who brought a new dynamic and opened up new markets .

MCAI took every opportunities and moved into various sectors such as HealthCare by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces.

3
2012_Octopus Robots

MCAI has decided to massively invest in the development of innovative robots and hired a team of specialists. Since then, the company is exclusively devoted to develop its range of Octopus robots.

4
2012 - 2014_Vision

In 2012, our Company moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces. It developed an innovative airborne disinfection system and sold it through a network of distributors worldwide.

In 2014, we moved into robotics completely. The “Octopus program” came alive.

5
2016 - 2017_Award & Renamed

The company was awarded the INNOV’SPACE’s Trophy for its Octopus Poultry Safe robot. Since June 2017 MCAI SAS becomes OCTOPUS ROBOTS SA.

6
2019 - 2020 _ Covir powered by Octopus Robots

Covir powered by www.octopusrobots.com for the financing of international licenses for robotic disinfection systems based on the Tezos blockchain.

7
Q2 2020 _ TECHNICAL INFO

As Covir continues to expand, we planned to publish various additional information regarding to operation of Covir (Royalties System, Tezos, multilingual)

8
Q2 2020 _ WALLET

Publication and availability of our wallet software for general public With different options. (Alpha version)

9
Q3 2020 _ DEVELOPMENT

We will continue our development with the launch of the CVR pre-sale etc...

10
Q3-3 2020 _ ROYALTIES & EXCHANGE

At the end of the third quarter, our investors will receive their first royalties. Distributions of Profits

11
Q4 2020 _ IEO

Major announcement for COVIR, with the launch of the IEO on a reputable exchange.

12
Q4 2020 _ OFFICIAL LISTING

Our token will then be listed at the end of our IEO, on the same exchange.

Project team

Olivier Somville
Olivier Somville
Founder & CEO
Marie Somville
Marie Somville
Marketing & Communications Latin America
Marie Somville linkedin
Bertrand Vergne
Bertrand Vergne
CEO
Bertrand Vergne linkedin
William Baude
William Baude
CTO
William Baude linkedin
Jacques Point
Jacques Point
CFO & STO Expert
Jacques Point linkedin
Jerome Leboeuf
Jerome Leboeuf
Director R&D Software/Hardware
Zied Chaabane
Zied Chaabane
Arabic Manager & Project Manager
Vu Viet Anh
Vu Viet Anh
Vietnam Manager
Vu Viet Anh linkedin
Sergei Lesnikov
Sergei Lesnikov
CMO, Marketing Manager
Sergei Lesnikov linkedin
Peter Cris Nabida
Peter Cris Nabida
Marketing Consultant
Peter Cris Nabida linkedin

Social media

Covir web-siteCovir RedditCovir MediumCovir TelegramCovir BTCTalkCovir LinkedInCovir X (Twitter)Covir FacebookCovir Github

Leave a Reply

Your email address will not be published. Required fields are marked *

Sponsored Crypto Projects

Newly Published